Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02214212 · ClinicalTrials.gov registry record · NA
TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT02214212 is a NA study that has completed, run by University of Washington. The registered enrollment target is 131 participants.
The verdict
NCT02214212, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
This study proposes to investigate how well Bright White Light Therapy will work in the acute inpatient rehabilitation units for people whom have experienced a traumatic brain injury for the purpose of treating sleep disruption. Participants will be assessed based on sleep efficiency, thinking abilities, therapy participation, and perception of fatigue/sleepiness. In previous studies dim red light has not had the same effects on function as bright white light, and will be chosen for use as a placebo. Each subject will be randomized to receive 30 minutes of either Bright White Light Therapy or Red Light Treatment each morning for 10 days. To measure the effect of this treatment, the investigators will measure the each participants sleep daily by using an actigraph watch. This watch will record movement continuously. The investigators will also measure the subjects' report of how well they slept, whether fatigue is present, and how attentive they are before and after treatment. Research Hypothesis: In persons with TBI, prospectively compare overnight sleep in a cohort exposed to morning Bright White Light with a comparison group exposed to Red Light in an acute inpatient rehabilitation setting.
Interventions
- DEVICE Bright White Light (BWL)
- DEVICE Red Light (RL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02214212
The ClinicalTrials.gov registry entry for NCT02214212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bright White Light (BWL) is the first listed.
NCT02214212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02214212 about?
NCT02214212 is a clinical study titled "TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI". This study proposes to investigate how well Bright White Light Therapy will work in the acute inpatient rehabilitation units for people whom have experienced a traumatic brain injury for the purpose of treating sleep disruption. Participants will be assessed based on sleep efficiency, thinking abili...
What is the current status of trial NCT02214212?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2013-12. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02214212?
The interventions under investigation include: Bright White Light (BWL) (DEVICE), Red Light (RL) (DEVICE).
Who is sponsoring clinical trial NCT02214212?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.